J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 72 (1991), 1445-1449; DOI 10.1099/0022-1317-72-6-1445
© 1991 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ludvíková, V.
Right arrow Articles by Vonka, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ludvíková, V.
Right arrow Articles by Vonka, V.
Agricola
Right arrow Articles by Ludvíková, V.
Right arrow Articles by Vonka, V.

Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant

Viera Ludvíková1, David Kunke2, Eva Hamsíková1, Luda Kutinová1 and Vladimír Vonka1

1 Department of Experimental Virology, Institute of Sera and Vaccines, Korunni 108, 101 03 Prague, Czechoslovakia
and2 Institute of Organic Chemistry and Biochemistry, Flemingovo nám. 2, 106 02 Prague, Czechoslovakia

Several vaccinia virus (VV)-varicella-zoster virus (VZV) recombinants expressing glycoprotein I (gpI) of VZV were isolated from the Prague strain of VV. One of these, v46, was inoculated intraperitoneally into mice. Groups of mice were bled 4 and 8 weeks later and their sera were examined for anti-VZV and anti-VV antibodies by ELISA. At 4 weeks, all mice inoculated with the three largest virus doses (107, 106 and 105 p.f.u.), and at 8 weeks all mice inoculated with the four highest virus doses (107, 106, 105 and 104 p.f.u.), had developed both anti-VV and anti-VZV antibodies. Antibodies were also detected in a high proportion of mice infected with lower doses of virus and in some instances VZV antibodies were present in the absence of VV antibodies. None of the animals inoculated in parallel with either a thymidine kinase-negative mutant of the original VV or diluent alone developed antibody reactive with VZV. The specificity of the reaction was assessed further by Western blotting using anti-gpI monoclonal antibodies as a positive control. Sera from animals immunized with v46 possessed antibody capable of neutralizing extracellular VZV in the presence of complement.

Received 24 May 1990; accepted 6 March 1991.


This article has been cited by other articles:


Home page
J. Virol.Home page
L. Maresova, T. J. Pasieka, and C. Grose
Varicella-Zoster Virus gB and gE Coexpression, but Not gB or gE Alone, Leads to Abundant Fusion and Syncytium Formation Equivalent to Those from gH and gL Coexpression
J. Virol., October 1, 2001; 75(19): 9483 - 9492.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. Kutinová, V. Ludví ková, L. Maresov á, s. Neme cková, J. Broucek, P. Hainz, and V. Vonka
Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence
J. Gen. Virol., November 1, 1999; 80(11): 2901 - 2908.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1991 by the Society for General Microbiology.